Thermo Fisher (TMO) analyst forecast and price target
Analyst forecast
Consensus of 30 analyst ratings
Based on 8 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Overweight | $650.00 from $620.00 | Jul 27, 2026 |
| Piper Sandler | Maintained | Neutral | $600.00 from $510.00 | Jul 27, 2026 |
| Barclays | Maintained | Overweight | $650.00 from $625.00 | Jul 24, 2026 |
| RBC Capital | Maintained | Sector Perform | $580.00 from $490.00 | Jul 24, 2026 |
| Evercore ISI Group | Maintained | Outperform | $570.00 from $575.00 | Jul 6, 2026 |
| Bernstein | Maintained | Market Perform | $520.00 | Jun 26, 2026 |
| Piper Sandler | Initiated Coverage | Neutral | $510.00 | Jun 11, 2026 |
| HSBC | Downgraded | Buy → Hold | $540.00 from $670.00 | Jun 3, 2026 |
| Wolfe Research | Initiated Coverage | Outperform | $535.00 | Jun 2, 2026 |
| Wells Fargo | Maintained | Overweight | $615.00 from $675.00 | May 8, 2026 |
| Stifel | Maintained | Buy | $600.00 from $700.00 | Apr 24, 2026 |
| Baird | Maintained | Outperform | $639.00 from $653.00 | Apr 24, 2026 |
| Barclays | Maintained | Overweight | $625.00 from $650.00 | Apr 14, 2026 |
| Evercore ISI Group | Maintained | Outperform | $575.00 from $650.00 | Apr 6, 2026 |
| Barclays | Maintained | Overweight | $650.00 from $625.00 | Jan 30, 2026 |
| TD Cowen | Maintained | Buy | $683.00 from $696.00 | Jan 30, 2026 |
| Citigroup | Maintained | Buy | $685.00 from $660.00 | Jan 30, 2026 |
| Stifel | Maintained | Buy | $700.00 from $583.00 | Jan 9, 2026 |
| TD Cowen | Maintained | Buy | $696.00 from $654.00 | Jan 7, 2026 |
| Wells Fargo | Maintained | Overweight | $675.00 from $635.00 | Dec 15, 2025 |
Frequently asked questions
What is the price target for TMO stock?
The average 12-month analyst price target for Thermo Fisher (TMO) is $580.63, with a high estimate of $650.00 and a low of $520.00, across 8 analysts.
Is TMO a buy, sell, or hold?
Analysts covering Thermo Fisher currently average a Buy rating: 24 buy, 6 hold and 0 sell, from 30 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for TMO?
The average price target of $580.63 implies 5.59% downside from the last price of $615.02.
What is the latest analyst rating on TMO?
On Jul 27, 2026, Morgan Stanley maintained Thermo Fisher at Overweight with a price target of $650.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.